Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$62.17 - $97.62 $4.09 Million - $6.43 Million
-65,830 Reduced 28.1%
168,440 $16.4 Million
Q4 2022

Feb 10, 2023

SELL
$60.21 - $77.74 $363,066 - $468,772
-6,030 Reduced 2.51%
234,270 $14.6 Million
Q3 2022

Nov 09, 2022

BUY
$72.92 - $99.73 $17.5 Million - $24 Million
240,300 New
240,300 $17.5 Million
Q1 2018

May 15, 2018

SELL
$58.36 - $83.18 $17.3 Million - $24.7 Million
-297,105 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$77.49 - $98.41 $23 Million - $29.2 Million
297,105
297,105 $23.8 Million

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.